Lantern Pharma Inc. · NASDAQ:LTRN
Thomas A. Satterfield, Jr. reported a 5.10% stake in Lantern Pharma Inc. (Schedule 13G)
Event Mar 30, 2026 · Filed Apr 3, 2026
Thomas A. Satterfield, Jr. reported a 5.10% stake in Lantern Pharma Inc., 570,000 shares, as a passive investor on Mar 30, 2026. Filed Apr 3, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 570,000
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Thomas A. Satterfield, Jr. | 5.10% | 570,000 |
Source
Related
- Lantern Pharma Inc.
- Thomas A. Satterfield, Jr.
- Lantern Pharma Inc. shareholders
- Schedule 13G/A · Thomas A. Satterfield, Jr. · Jul 23, 2026
- Schedule 13G/A · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · Empery Asset Management, LP · Aug 4, 2026
- Schedule 13D/A · BIOS Advisors GP, LLC · May 15, 2026
- Form 4 · Schalop Lee Troy · May 14, 2026
- Form 4 · Keyser D Jeffrey · May 14, 2026